Target intelligence / Profile preview

Long intergenic non-protein coding RNA 678 (LINC00678)

Target
LINC00678
Molecular classification
Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

LINC00678 (long intergenic non-protein coding RNA 678) is a human gene that encodes a long intergenic non-coding RNA (lincRNA) transcript. lincRNAs are defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes. They participate in diverse aspects of cell biology including chromatin remodeling, gene regulation (either locally or distantly), and possibly enhancer-like activity, with high tissue specificity. While many lincRNAs have been linked to diseases such as cancer and developmental disorders, the specific cellular role of LINC00678 itself remains unclear. Its expression may be involved in cell differentiation pathways, as its transcript levels can change during differentiation, but detailed mechanistic or disease associations have not been ascribed to this gene. LINC00678 is not a protein and does not serve as a classical drug target, receptor, enzyme, or transporter, but may have regulatory or biomarker potential in human health and disease.

Other names
LINC00678Long intergenic non-protein coding RNA 678
02

Mechanism of action

Not applicable. As no drugs targeting LINC00678 exist, mechanisms of action cannot be assigned

03

Biological functions

Regulation of gene expressionChromatin remodelingTissue-specific transcript regulation and potential enhancer-associated activityPossible involvement in regulation of pluripotency and differentiation processes, based on transcriptomic data
04

Disease associations

Potential involvement in cancer (lincRNAs as a class, with some evidence that LINC00678 and similar lincRNAs may be linked to cancer pathways or could serve as putative biomarkers)Possible involvement in cell fate decisions, stem cell differentiation, and other developmental pathways (by analogy with other lincRNAs)
05

Biomarkers

LINC00678 and related lincRNAs have been studied as molecular markers in some disease contexts (notably cancer), according to patent databases and reviews of non-coding RNA functions, but no validated, widely accepted biomarker role for LINC00678 itself is listed

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 678 (LINC00678).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 678 (LINC00678).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call